Journal of Clinical Toxicology

Journal of Clinical Toxicology
Open Access

ISSN: 2161-0495

+44 1478 350008

Review Article - (2018) Volume 8, Issue 2

Tricyclic Antidepressant Drug Intoxication: Is there a Role for Lipid Emulsion Therapy?

Ozgur Karcioglu*
Department of Emergency, Istanbul Training and Research Hospital, University of Health Sciences, Fatih, Istanbul, Turkey
*Corresponding Author: Ozgur Karcioglu, Department of Emergency, Istanbul Training and Research Hospital, University of Health Sciences, Fatih, Istanbul, Turkey Email:

Abstract

Lipid resuscitation therapy is the administration of Intravenous Lipid Emulsions (ILE) with the intent of reducing the clinical manifestations of toxicity from drug overdoses; including local anesthetics, calcium-channel blockers, β- blockers, antipsychotics, tricyclic antidepressant drugs (TCAD) and other compounds. Although there are conflicting findings in the literature, ILE may be considered for resuscitation in emergency and intensive care in resuscitation of severe hemodynamic compromise by TCAD.

This article reviews recent literature to analyse consequences, and intended effects associated with this treatment modality in poisoning with TCAD.

Keywords: Lipid emulsion; Lipid emulsion therapy; Intoxication, Poisoning; Tricyclic antidepressant drugs; Amitriptylin

Tricyclic Antidepressant Drug Intoxication: Is there a Role for Lipid Emulsion Therapy?

Tricyclic antidepressant drugs (TCADs)

TCADs have been among the most important instruments for the treatment of depression in the last century. Highly toxic potential of the drugs has been a major drawback and resulted in substitution by alternatives in time [1]. Similar to the toxicity with opiates, analgesics, and benzodiazepines, TCAD poisonings have been highly lethal in the human being so far [2]. Toxicity with TCAD results predominantly from myocardial sodium-channel blockade and associated ventricular dysrhythmias, myocardial depression, and hypotension. Main therapy encompasses supportive care, antidysrhythmics when necessary, and systemic alkalinization with sodium bicarbonate infusion. The patients receive treatment with activated charcoal for gastric decontamination, intravenous sodium bicarbonate, intravenous lipid emulsion (ILE) therapy, and plasmapheresis.

Sodium channel blockade accompanied by antimuscarinic effects and a-adrenoceptor antagonism are characteristics in TCAD overdose. These effects lead to a rhythm with a wide QRS complex that may resemble ventricular tachycardia. QRS duration was postulated to be a marker of outcome in these patients. A well-designed study in TCAD poisoning showed that a QRS duration below 100 ms was an indicator of favorable outcome, whereas a QRS greater than 100 ms was associated with seizures probability, and longer than 160 ms was associated with increased risk of dysrhythmia [3].

What are lipid emulsions?

The first successful ILE was launched in the sixties as a mainstay in parenteral nutrition. In the following decades, the new generations of fat emulsions were devised, with increasing olive oil and fish oil content while the soybean oil mixture declined [4].

ILE is a 20% free fatty acid mixture used to deliver parenteral calories to those unable to take oral nutrition [5]. ILE is administered to reduce the clinical signs of toxicity from overdoses of some medications, including local anesthetics, beta blockers, calcium channel blockers, TCADs and other drugs [6]. This article reviews the rationale for and effectiveness of the introduction of ILE as treatment for TCAD poisoning in the emergency setting.

Some mechanisms of action of ILE in the management of poisoning are believed to work for the effectiveness of ILE. The ‘lipid sink’ phenomenon is the most widely accepted mechanism of action for ILE, which involves surrounding a lipophilic drug molecule and rendering it ineffective [7,8]. Animal studies show efficacy of ILE in the treatment of severe cardiotoxicity associated with local anesthetics, clomipramine, and verapamil, possibly by trapping such lipophilic drugs in an expanded plasma lipid compartment ("lipid sink").

The partitioning theory, or lipid sink theory, postulates that the administration of lipids compartmentalizes the offending xenobiotic into lipid phase and away from the target receptors. The generation of a concentration gradient facilitate the removal of the offending agent from tissues via different serum concentrations [7,9,10]. Another suggested mechanism involves drug-induced disruption of cellular calcium transport and claims that the function can be restored by activating calcium channels by ILE [11]. In brief, a sufficiently lipidsoluble compound becomes bound within these oil droplets, pulling drug from target tissues and sequestering them [12].

Clinical use, dosing and drawbacks: ILE has been extensively employed in the treatment of lipophilic drug poisonings following the first successful use of ILE in non-local anesthetic poisoning by Sirianni et al. [13]. The American College of Medical Toxicology (ACMT) recommends that ILE be used for poisoned patients with hemodynamic or other instability not responding to standard resuscitation measures [6].

The dose most commonly used is 1.5 mL/kg of 20% lipid emulsion infused as a bolus, repeated up to twice (some authors recommend up to three times) as needed until clinical stability is achieved, and followed by an infusion of 0.25 mL/kg/min for 30 to 60 min [14]. The infusion rate may be titrated to effect if the patient’s blood pressure drops. The Food and Drug Administration fixed a maximum total dose administered per 24 h of 12.5 mL/kg [15]. The upper limits of therapy in case of persistent cardiovascular collapse or hemodynamic instability have not been established so far. American Society of Regional Anesthesia (ASRA) recommends the upper limits of 10 mL/kg over 30 min (Table 1) [16].

Bolus 1.5 mL/kg (lean body mass) IV over 1 min Continuous infusion 0.25 mL/kg/min
100 mL for a 70-kg patient 18 mL/min for a 70-kg patient
Repeat bolus for persistent cardiovascular collapse Can double the infusion rate for persistent hemodynamic instability
  Continue infusion for at least ten minutes after hemodynamic recovery

Table 1: Current recommendation from American Society of Regional Anesthesia (ASRA) for 20% lipid emulsion.

Fortunately, adverse reactions are uncommon despite widespread use of ILE. Adverse effects from standard procedure of ILE comprise hypertriglyceridemia, fat embolism, infection, local vein irritation, acute pancreatitis, electrolyte disturbances and hypersensitivity and allergic reactions. Untoward effects can also encompass kidney injury, cardiac arrest, ventilation-perfusion mismatch, acute lung injury, venous thromboembolism, fat overload syndrome, extracorporeal circulation machine circuit obstruction, and increased susceptibility to infections [17]. In addition, practice of ILE can accompany disturbed laboratory values such that hyperlipemia, hypercoagulability, and thrombopenia in neonates.

The untoward effects encountered with the use of ILE as part of nutrition can be categorized as early or delayed reactions. Early reactions include allergic reactions, dyspnea, cyanosis, nausea, vomiting, headache, flushing, fever, sweating, sleepiness and pain in the torso, pressure over the eyes, dizziness, and irritation at the site of infusion [18]. Hepatotoxicity is typical of delayed adverse reactions which may comprise minimal elevations of enzymes or minimal parenchymal damage to fulminant liver disease presenting with jaundice and pancytopenia [19,20].

Use of ILE in TCAD overdoses: Although ILE was launched to be a rescue treatment for local anesthetic poisoning, many antipsychotic or antidepressant medications also represent treatment targets with ILE because of the lipophilicity needed to cross the blood-brain barrier and because of their structural similarity to local anesthetics. Muller et al. reported 39 cases with local anesthetic poisoning successfully reversed by ILE [21]. The second most common drug toxicity to be successfully reversed by ILE was amitriptyline, a TCAD, which was reported in six cases. It should be noted that there are contradictory reports with regard to the efficacy of ILE in the treatment of toxicity of TCAD.

Levine et al. published a systematic review on non-local anesthetic toxicity [22]. A total of 203 articles (141 for humans and 62 for animals) were included. They concluded that despite the use of ILE for multiple substances in the treatment of patients with poisoning and overdose, the effect of ILE in various non-local anesthetic poisonings is heterogenous, and the quality of evidence remains low to very low.

There is dearth of data regarding human studies about use of ILE in TCAD overdose. In a small study in which humans were given therapeutic doses of TCAD and ILE [23], patients treated with ILE developed a non-significant increase in blood level of TCAD, which would support the hypothesis that ILE attracts TCAD away from tissues by creating an expanded lipid compartment.

Although clear-cut evidence has not been published to date, Toxbase recommended use of ILE when there are life-threatening arrhythmias resistant to the other “standard” modes of treatment [24]. On the other hand, Tabone et al. conducted a Best Bets literature search in 2010 and reported that there was no clear evidence about the effectiveness of ILE in TCAD overdose [25].

Jamaty et al. reviewed 23 animal and 50 human trials involving use of ILE in the management of poisoning [26]. ILE has certain benefits in poisoning scenarios with bupivacaine, verapamil, chlorpromazine, and some TCAD and beta-blockers. The effective use of ILE for TCAD intoxication was demonstrated in a number of animal models [27-30]. However, the evidence for the efficacy of ILE in reducing mortality and improving hemodynamic, electrocardiographic, and neurological parameters in the poisoned patients is solely based on animal studies and human case reports [26].

Amitriptyline: Many reports in which amitriptyline overdoses were treated with ILE have been published to date [30-36]. There were no differences in ECG parameters and no severe cardiac arrhythmias occurred. Thus ILE was able to entrap amitriptyline back into plasma from brain and possibly from other highly perfused, lipid-rich tissues. In spite of the entrapment, there was no difference in haemodynamics between the groups.

Gosselin et al. published “evidence-based recommendations on the use of ILE therapy in poisoning” with a variety of culprit drugs including amitriptyline and other TCAD [37]. In their “executive summary of indications regarding the use of ILE in poisoning” they recommended to use ILE if other therapies fail/in last resort in life-threatening toxicity. In non-life-threatening toxicity, on the other hand, they did not suggest using ILE as part of treatment modalities.

Varney et al. conducted a randomized, controlled pilot study in a swine model to compare efficacy of ILE with standard treatment of sodium bicarbonate to reverse amitriptyline-induced hypotension in the course of severe TCAD overdose [38]. They reported that ILE failed to improve hypotension when compared to the standard treatment of sodium bicarbonate in this model. On the other hand, in a rodent model of TCAD oral poisoning, Perichon et al. administered ILE 30 min after oro-gastric administration of amitriptyline and compared the effects with 70% bicarbonate vs 70% Hartmann's solution [39]. Treatment with ILE early after oral amitriptyline overdose resulted in worse survival and no improvement in haemodynamics. The authors pointed out that either drug absorption from the gastrointestinal tract was facilitated or drug redistribution was delayed when ILE was instituted early after oral poisoning.

Rabbit models have demonstrated the effectiveness of lipid as a treatment for IV TCAD toxicity [27,40,41]. Furthermore, in pig studies, lipid is shown to entrap amitriptyline into the plasma, which fits into the scavenging theory. Heinonen et al. used ILE in the management of severe amitriptyline poisoning in a pig model and indicated that a significant (25%) decrease in brain amitriptyline concentrations were noted following treatment with 20% ILE when compared to Ringer's acetate administration [42].

Desipramine: As a member of the TCAD family, toxic ingestion of desipramine triggers fatal dysrhythmias and a systole. O’Sullivan et al. compared the efficacy of the drugs and drug combinations given concurrent with cardiopulmonary resuscitation in pigs with desipramine overdose [43]. They reported that animals treated with ILE + vasopressin were more likely to survive than those treated only with ILE, and the groups that received ILE were more likely to survive than those not treated with ILE. In the present study, ILE infusions were not as beneficial as expected in desipramine poisoning.

Clomipramine: Harvey and Cave compared efficacy of resuscitation with ILE versus sodium bicarbonate in a rabbit model of clomipramine toxicity [27]. Infusion of ILE led to more rapid and complete reversal of clomipramine-induced hypotension compared with sodium bicarbonate. Additionally, ILE infusion prevented cardiovascular collapse in a model of severe clomipramine toxicity.

In a rabbit model of clomipramine toxicity, Cave et al. reported that both ILE and tailored liposomes improved hemodynamic recovery compared with bicarbonate in clomipramine-induced cardiotoxicity in rabbits [44]. ILE group also had higher 30-minute blood pressure readings. In another model of TCAD toxicity, Harvey et al. sought for additional benefit with plasma exchange therapy undertaken subsequent to ILE treatment, hypothesising enhanced blood carriage of lipophilic toxin clomipramine to increase yield when combined with an extracorporeal mode of elimination [45]. Plasma exchange performed in conjunction with administration of ILE failed to result in significant extracorporeal clomipramine elimination and ILE resulted in greater survival.

Dothiepin (Dosulepin): So far, only a few case reports have been published to extrapolate efficacy of treatment with ILE in dothiepin overdose and cardiotoxicity [46,47].

Conclusion

Acute poisoning with TCAD is difficult to treat and consists mainly of haemodynamic and ventilatory support. Clinical efficacy of ILE is firmly established in many reports to resuscitate patients with cardiotoxicity from systemic toxicity of different compounds in the TCAD family. ILE is a potential antidote for this phenomenon under extreme circumstances. Further research concerning the safety of ILE is needed before it is recommended as the first choice treatment modality for acute TCAD overdose.

References

  1. Kerr GW, McGuffie AC, Wilkie S (2001) Tricyclic antidepressant overdose: a review. Emerg Med J 18: 236-241.
  2. Liebelt EL, Ulrich A, Francis PD, Woolf A (1997) Serial electrocardiogram changes in acute tricyclic antidepressant overdoses. Crit Care Med 25: 1721-1726.
  3. Vanek VW, Seidner DL, Allen P, Bistrian B, Collier S, et al. (2012) A.S.P.E.N. Position Paper Clinical Role for Alternative Intravenous Fat Emulsions. Nutr Clin Pract 27: 150-192.
  4. Driscoll DF (2006) Lipid injectable emulsions: pharmacopeial and safety issues. Pharm Res  23: 1959-1969.
  5. American College of Medical Toxicology (2011) ACMT Position Statement: Interim Guidance for the Use of Lipid Resuscitation Therapy. J Med Toxicol 7: 81-82.
  6. Weinberg G, Lin B, Zheng S, Di Gregorio G, Hiller D, et al. (2010) Partitioning effect in lipid resuscitation: further evidence for the lipid sink. Crit Care Med 38: 2268-2269.
  7. Samuels TL, Willers JW, Uncles DR, Monteiro R, Halloran C, et al. (2012) In vitro suppression of drug-induced methaemoglobin formation by intralipid 1 in whole human blood: observations relevant to the ‘lipid sink theory’. Anaesthesia 67: 23-32.
  8. French D, Smollin C, Ruan W, Wong A, Drasner K, et al. (2011) Partition constant and volume of distribution as predictors of clinical efficacy of lipid rescue for toxicological emergencies. Clin Toxicol (Phila) 49: 801-809.
  9. Weinberg GL, Ripper R, Murphy P, Edelman LB, Hoffman W, et al. (2006) Lipid infusion accelerates removal of bupivacaine and recovery from bupivacaine toxicity in the isolated rat heart. Reg Anesth Pain Med 31: 296-303.
  10. Presley JD, Chyka PA (2013) Intravenous lipid emulsion to reverse acute drug toxicity in pediatric patients. Ann Pharmacother 47: 735-743.
  11. Weinberg GL (2012) Lipid emulsion infusion resuscitation for local anesthetic and other drug overdose. Anesthesiology 117: 180-187.
  12. Sirianni AJ, Osterhoudt KC, Calello DP, Muller AA, Waterhouse MR, et al. (2008) Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine. Ann Emerg Med 51: 412-415.
  13. Association of Anaesthetists of Great Britain and Ireland, AAGBI Safety Guideline: Management of Severe Local Anaesthetic Toxicity, 2010.
  14. Fettiplace MR, Akpa BS, Rubinstein I, Weinberg G (2015) Confusion about infusion: Rational volume limits for intravenous lipid emulsion during treatment of oral overdoses. Ann Emerg Med 66: 185-188.
  15. Cao D, Heard K, Foran M, Koyfman A (2015) Intravenous lipid emulsion in the emergency department: a systematic review of recent literature. J Emerg Med 48: 387-397.
  16. Hayes BD, Gosselin S, Calello DP, Nacca N, Rollins CJ, et al. (2016) Systematic review of clinical adverse events reported after acute intravenous lipid emulsion administration. Clin Toxicol (Phila) 54: 365-404.
  17. https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/017643s072,018449s039lbl.pdf
  18. Wanten G, Calder PC, Forbes A (2011) Managing adult patients who need home parenteral nutrition. BMJ 342: d1447.
  19. Tillman EM (2013) Review and clinical update on parenteral nutrition-associated liver disease. Nutr Clin Pract 28: 30-39.
  20. Muller SH, Diaz JH, Kaye AD (2015) Clinical applications of intravenous lipid emulsion therapy. J Anesth 29: 920-926.
  21. Levine M, Hoffman RS, Lavergne V, Stork CM, Graudins A, et al. (2016) Systematic review of the effect of intravenous lipid emulsion therapy for non-local anesthetics toxicity. Clin Toxicol (Phila) 54: 194-221.
  22. Minton N, Goode A, Henry J (1987) The effect of a lipid suspension on amitryptiline disposition. Arch Toxicol 60: 467e9.
  23. Tabone D (2010)Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 4: use of intralipid in tricyclic overdose. Emerg Med J 27: 396-397.
  24. Jamaty C, Bailey B, Larocque A, Notebaert E, Sanogo K, et al. (2010) Lipid emulsions in the treatment of acute poisoning: a systematic review of human and animal studies. Clin Toxicol (Phila) 48: 1-27. 
  25. Harvey M, Cave G (2007) Intralipid outperforms sodium bicarbonate in a rabbit model of clomipramine toxicity. Ann Emerg Med 49: 178-185.
  26. Bania T, Chu J (2006) Hemodynamic effect of intralipid in amitriptyline toxicity. Acad Emerg Med 13: 117.
  27. Levine M, Brooks DE, Franken A, Graham R (2012) Delayed-onset seizure and cardiac arrest after amitriptyline overdose, treated with intravenous lipid emulsion therapy. Pediatrics 130: 432-438.
  28. Harvey M, Cave G (2012) Case report: successful lipid resuscitation in multidrug overdose with predominant tricyclic antidepressant toxidrome. Int J Emerg Med 5: 8.
  29. Punja M, Neill SG, Wong S (2013) Caution with interpreting laboratory results after lipid rescue therapy. Am J Emerg Med 31: 1536.e1-1536.e2.
  30. Bowler M, Nethercott DR (2014) Two lessons from the empiric management of a combined overdose of liraglutide and amitriptyline. A A Case Rep 2: 28-30.
  31. Eren CS, Tasyurek T, Guneysel O (2014) Intralipid emulsion treatment as an antidote in lipophilic drug intoxications. Am J Emerg Med 32: 1103-1108.
  32. Agarwala R, Ahmed SZ, Wiegand TJ (2014) Prolonged use of intravenous lipid emulsion in a severe tricyclic antidepressant overdose. J Med Toxicol 10: 210-214.
  33. Kiberd MB, Minor SF (2012) Lipid therapy for the treatment of a refractory amitriptyline overdose. Can J Emerg Med 14: 193-197.
  34. Gosselin S, Hoegberg LC, Hoffman RS, Graudins A, Stork CM, et al. (2016) Evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning. Clin Toxicol (Phila) 54: 899-923.
  35. Varney SM, Bebarta VS, Vargas TE, Boudreau S, Castaneda M, et al. (2014) Intravenous lipid emulsion therapy does not improve hypotension compared to sodium bicarbonate for tricyclic antidepressant toxicity: a randomized, controlled pilot study in a swine model. Acad Emerg Med 21: 1212-1219.
  36. Perichon D, Turfus S, Gerostamoulos D, Graudins A (2013) An assessment of the in vivo effects of intravenous lipid emulsion on blood drug concentration and haemodynamics following oro-gastric amitriptyline overdose. Clin Toxicol (Phila) 51: 208-215.
  37. Cave G, Harvey M, Quinn P, Heys D (2013) Hypertonic sodium bicarbonate versus intravenous lipid emulsion in a rabbit model of intravenous flecanide toxicity: no difference, no sink. Clin Toxicol 51: 394-397.
  38. Harvey M, Cave G, Hoggett K (2009) Correlation of plasma and peritoneal diasylate clomipramine concentration with hemodynamic recovery after intralipid infusion in rabbits. Acad Emerg Med 16: 151-156.
  39. Heinonen JA, Litonius E, Backman JT, Neuvonen PJ, Rosenberg PH, et al. (2013) Intravenous lipid emulsion entraps amitriptyline into plasma and can lower its brain concentration-an experimental intoxication study in pigs. Basic Clin Pharmacol Toxicol 113: 193-200.
  40. O'Sullivan JC, Johnson AD, Waterman MA (2014) Comparative resuscitation measures for the treatment of desipramine overdose. 179: 1266-1272. 
  41. Cave G, Harvey M, Shaw T, Damitz R, Chauhan A, et al. (2013) Comparison of intravenous lipid emulsion, bicarbonate, and tailored liposomes in rabbit clomipramine toxicity. Acad Emerg Med 20: 1076-1079.
  42. Harvey M, Cave G, Ong B (2014) Intravenous lipid emulsion-augmented plasma exchange in a rabbit model of clomipramine toxicity; survival, but no sink. Clin Toxicol (Phila) 52: 13-19. 
  43. Blaber MS, Khan JN, Brebner JA, McColm R (2012) "Lipid rescue" for tricyclic antidepressant cardiotoxicity. J Emerg Med 43: 465-467.
  44. Boegevig S, Rothe A, Tfelt-Hansen J, Hoegberg LC (2011) Successful reversal of life threatening cardiac effect following dosulepin overdose using intravenous lipid emulsion. Clin Toxicol (Phila) 49: 337-339.
Citation: Karcioglu O (2018) Tricyclic Antidepressant Drug Intoxication: is there a role for Lipid Emulsion Therapy?. J Clin Toxicol 8: 376.

Copyright: © 2018 Karcioglu O, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top